The University of Arkansas for Medical Sciences received a $10.5 million NIH grant to develop biomarkers for all human diseases, including cancer, through proteomics.
The Mount Sinai Tisch Cancer Center received the Comprehensive Cancer Center designation from NCI.Â
City of Hope is scheduled to open a cancer specialty hospital on its academic cancer campus in Orange County Dec. 1.
Darrow Zeidenstein was named chief development officer at the American Cancer Society and its advocacy affiliate the American Cancer Society Cancer Action Network. In this role, Zeidenstein will lead the organization’s development efforts, overseeing all aspects of resource generation, including corporate partnerships, philanthropy, planned giving, Discovery Shops, community-based fundraising, and revenue-generating field operations.Â
Erik Sulman will serve as the interim executive director of the Duke Cancer Institute, effective Jan. 5, 2026.Â
Richard Turman announced that he will be stepping down from leadingAct for NIH, an NIH advocacy organization, and its affiliated education arm ACT for NIH Foundation, effective Jan. 1, 2026. xxx:moreNIH and FDA lea
UAMS Cancer Institute director Michael Birrer inducted into American Academy of Sciences and Letters
Michael J. Birrer, director of the Winthrop P. Rockefeller Cancer Institute at the University of Medical Sciences, has been inducted as a member of the American Academy of Sciences and Letters. xxx:moreBirrer was among more than 60 distinguished scholars inducted during a ceremony Nov. 12 at the historic Decatur House in Washi
Onboard AI and Cedars-Sinai will collaborate to deploy an automated, AI-native governance platform that health systems can use to streamline and strengthen the evaluation, approval, and monitoring of AI solutions.
UCLA Health has established the Department of Nuclear Medicine and Theranostics—the first of its kind in the United States. The new department will integrate advanced imaging and therapy, accelerate scientific discovery, and advance precision health at UCLA Health.
ChristianaCare’s Cawley Center for Translational Cancer Research has established an organoid core.
